FDA Inspection 798256 — ChiRhoClin, Inc
The FDA completed an inspection of ChiRhoClin, Inc on Sep 7, 2012 in Burtonsville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 7, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Burtonsville, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)